{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:32:16Z","timestamp":1792812736197,"version":"4.5.0"},"reference-count":27,"publisher":"Rockefeller University Press","issue":"6","content-domain":{"domain":["rupress.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,6,8]]},"abstract":"<jats:p>Threats of bioterrorism have renewed efforts to better understand poxvirus pathogenesis and to develop a safer vaccine against smallpox. Individuals with atopic dermatitis are excluded from smallpox vaccination because of their propensity to develop eczema vaccinatum, a disseminated vaccinia virus (VACV) infection. To study the underlying mechanism of the vulnerability of atopic dermatitis patients to VACV infection, we developed a mouse model of eczema vaccinatum. Virus infection of eczematous skin induced severe primary erosive skin lesions, but not in the skin of healthy mice. Eczematous mice exhibited lower natural killer (NK) cell activity but similar cytotoxic T lymphocyte activity and humoral immune responses. The role of NK cells in controlling VACV-induced skin lesions was demonstrated by experiments depleting or transferring NK cells. The proinflammatory cytokine interleukin (IL)-17 reduced NK cell activity in mice with preexisting dermatitis. Given low NK cell activities and increased IL-17 expression in atopic dermatitis patients, these results can explain the increased susceptibility of atopic dermatitis patients to eczema vaccinatum.<\/jats:p>","DOI":"10.1084\/jem.20082835","type":"journal-article","created":{"date-parts":[[2009,5,25]],"date-time":"2009-05-25T20:45:29Z","timestamp":1243284329000},"page":"1219-1225","update-policy":"https:\/\/doi.org\/10.1084\/jem.crossmarkpolicy","source":"Crossref","is-referenced-by-count":76,"title":["Inhibition of NK cell activity by IL-17 allows vaccinia virus to induce severe skin lesions in a mouse model of eczema vaccinatum"],"prefix":"10.1084","volume":"206","author":[{"given":"Yuko","family":"Kawakami","sequence":"first","affiliation":[{"name":"Division of Cell Biology 1 , 2 , and 3"},{"name":"Division of Vaccine Discovery 1 , 2 , and 3"},{"name":"Center for Infectious Disease, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037 1 , 2 , and 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Tomimori","sequence":"additional","affiliation":[{"name":"Division of Cell Biology 1 , 2 , and 3"},{"name":"Division of Vaccine Discovery 1 , 2 , and 3"},{"name":"Center for Infectious Disease, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037 1 , 2 , and 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Yumoto","sequence":"additional","affiliation":[{"name":"Division of Cell Biology 1 , 2 , and 3"},{"name":"Division of Vaccine Discovery 1 , 2 , and 3"},{"name":"Center for Infectious Disease, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037 1 , 2 , and 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunji","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Division of Cell Biology 1 , 2 , and 3"},{"name":"Division of Vaccine Discovery 1 , 2 , and 3"},{"name":"Center for Infectious Disease, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037 1 , 2 , and 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoaki","family":"Ando","sequence":"additional","affiliation":[{"name":"Division of Cell Biology 1 , 2 , and 3"},{"name":"Division of Vaccine Discovery 1 , 2 , and 3"},{"name":"Center for Infectious Disease, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037 1 , 2 , and 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Tagaya","sequence":"additional","affiliation":[{"name":"Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shane","family":"Crotty","sequence":"additional","affiliation":[{"name":"Division of Cell Biology 1 , 2 , and 3"},{"name":"Division of Vaccine Discovery 1 , 2 , and 3"},{"name":"Center for Infectious Disease, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037 1 , 2 , and 3"},{"name":"Division of Cell Biology 1 , 2 , and 3"},{"name":"Division of Vaccine Discovery 1 , 2 , and 3"},{"name":"Center for Infectious Disease, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037 1 , 2 , and 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Kawakami","sequence":"additional","affiliation":[{"name":"Division of Cell Biology 1 , 2 , and 3"},{"name":"Division of Vaccine Discovery 1 , 2 , and 3"},{"name":"Center for Infectious Disease, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037 1 , 2 , and 3"},{"name":"Division of Cell Biology 1 , 2 , and 3"},{"name":"Division of Vaccine Discovery 1 , 2 , and 3"},{"name":"Center for Infectious Disease, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037 1 , 2 , and 3"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"291","published-online":{"date-parts":[[2009,5,25]]},"reference":[{"key":"2023072920142432600_bib1","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1172\/JCI21060","article-title":"New insights into atopic dermatitis","volume":"113","author":"Leung","year":"2004","journal-title":"J. Clin. Invest."},{"key":"2023072920142432600_bib2","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1067\/mai.2002.128052","article-title":"Smallpox vaccination: Risk considerations for patients with atopic dermatitis","volume":"110","author":"Engler","year":"2002","journal-title":"J. Allergy Clin. Immunol."},{"key":"2023072920142432600_bib3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0140-6736(03)12193-9","article-title":"Atopic dermatitis","volume":"361","author":"Leung","year":"2003","journal-title":"Lancet."},{"key":"2023072920142432600_bib4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jaci.2006.04.045","article-title":"New insights into the complex gene-environment interactions evolving into atopic dermatitis","volume":"118","author":"Leung","year":"2006","journal-title":"J. Allergy Clin. Immunol."},{"key":"2023072920142432600_bib5","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1067\/mai.2003.1414","article-title":"Polarized in vivo expression of IL-11 and IL-17 between acute and chronic skin lesions","volume":"111","author":"Toda","year":"2003","journal-title":"J. Allergy Clin. Immunol."},{"key":"2023072920142432600_bib6","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1038\/jid.2008.111","article-title":"Possible pathogenic role of Th17 cells for atopic dermatitis","volume":"128","author":"Koga","year":"2008","journal-title":"J. Invest. Dermatol."},{"key":"2023072920142432600_bib7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1615\/CritRevImmunol.v28.i1.20","article-title":"Scratching the surface: towards understanding the pathogenesis of atopic dermatitis","volume":"28","author":"Sehra","year":"2008","journal-title":"Crit. Rev. Immunol."},{"key":"2023072920142432600_bib8","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.0105-2896.2006.00392.x","article-title":"Immunity and immunological memory following smallpox vaccination","volume":"211","author":"Amanna","year":"2006","journal-title":"Immunol. Rev."},{"key":"2023072920142432600_bib9","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jaci.2003.07.001","article-title":"Viral infections in atopic dermatitis: pathogenic aspects and clinical management","volume":"112","author":"Wollenberg","year":"2003","journal-title":"J. Allergy Clin. Immunol."},{"key":"2023072920142432600_bib10","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/intimm\/9.3.461","article-title":"Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC\/Nga mice","volume":"9","author":"Matsuda","year":"1997","journal-title":"Int. Immunol."},{"key":"2023072920142432600_bib11","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2332\/allergolint.O-07-486","article-title":"An improved mouse model of atopic dermatitis and suppression of skin lesions by an inhibitor of tec family kinases","volume":"56","author":"Kawakami","year":"2007","journal-title":"Allergol. Int."},{"key":"2023072920142432600_bib12","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nri2276","article-title":"Evolutionary struggles between NK cells and viruses","volume":"8","author":"Lanier","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"2023072920142432600_bib13","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.it.2007.04.001","article-title":"Keeping NK cells in highly regulated antiviral warfare","volume":"28","author":"Lee","year":"2007","journal-title":"Trends Immunol."},{"key":"2023072920142432600_bib14","doi-asserted-by":"crossref","first-page":"4674","DOI":"10.4049\/jimmunol.136.12.4674","article-title":"Effect of rabbit anti-asialo GM1 treatment in vivo or with anti-asialo GM1 plus complement in vitro on cytotoxic T cell activities","volume":"136","author":"Stitz","year":"1986","journal-title":"J. Immunol."},{"key":"2023072920142432600_bib15","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1146\/annurev.immunol.25.022106.141557","article-title":"IL-17 family cytokines and the expanding diversity of effector T cell lineages","volume":"25","author":"Weaver","year":"2007","journal-title":"Annu. Rev. Immunol."},{"key":"2023072920142432600_bib16","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0065-2776(04)86006-1","article-title":"Interleukin-2, interleukin-15, and their roles in human natural killer cells","volume":"86","author":"Becknell","year":"2005","journal-title":"Adv. Immunol."},{"key":"2023072920142432600_bib17","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/1523-1747.ep12259055","article-title":"Modulation of natural killer cell activity in patients with atopic dermatitis","volume":"82","author":"Jensen","year":"1984","journal-title":"J. Invest. Dermatol."},{"key":"2023072920142432600_bib18","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1365-2222.1984.tb02232.x","article-title":"Natural-killer-cell activity in atopic dermatitis","volume":"14","author":"Lever","year":"1984","journal-title":"Clin. Allergy."},{"key":"2023072920142432600_bib19","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature."},{"key":"2023072920142432600_bib20","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature04754","article-title":"Transforming growth factor-beta induces development of the TH17 lineage","volume":"441","author":"Mangan","year":"2006","journal-title":"Nature."},{"key":"2023072920142432600_bib21","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nature05970","article-title":"IL-21 initiates an alternative pathway to induce proinflammatory TH17 cells","volume":"448","author":"Korn","year":"2007","journal-title":"Nature."},{"key":"2023072920142432600_bib22","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature05969","article-title":"Essential autocrine regulation by IL-21 in the generation of inflammatory T cells","volume":"448","author":"Nurieva","year":"2007","journal-title":"Nature."},{"key":"2023072920142432600_bib23","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/ni1488","article-title":"IL-6 programs TH-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways","volume":"8","author":"Zhou","year":"2007","journal-title":"Nat. Immunol."},{"key":"2023072920142432600_bib24","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1006\/viro.2002.1400","article-title":"Interleukin 17 modulates the immune response to vaccinia virus infection","volume":"299","author":"Patera","year":"2002","journal-title":"Virology."},{"key":"2023072920142432600_bib25","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.4049\/jimmunol.131.3.1531","article-title":"Natural killer cell depletion enhances virus synthesis and virus-induced hepatitis in vivo","volume":"131","author":"Bukowski","year":"1983","journal-title":"J. Immunol."},{"key":"2023072920142432600_bib26","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/ni714","article-title":"Specific and nonspecific NK cell activation during virus infection","volume":"2","author":"Dokun","year":"2001","journal-title":"Nat. Immunol."},{"key":"2023072920142432600_bib27","doi-asserted-by":"crossref","first-page":"7736","DOI":"10.4049\/jimmunol.176.12.7736","article-title":"NK cells and \u03b3\u03b4+ T cells are phenotypically and functionally defective due to preferential apoptosis in patients with atopic dermatitis","volume":"176","author":"Katsuta","year":"2006","journal-title":"J. Immunol."}],"container-title":["Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/rupress.org\/jem\/article-pdf\/206\/6\/1219\/1910161\/jem_20082835.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/rupress.org\/jem\/article-pdf\/206\/6\/1219\/1910161\/jem_20082835.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,29]],"date-time":"2023-07-29T16:15:01Z","timestamp":1690647301000},"score":1,"resource":{"primary":{"URL":"https:\/\/rupress.org\/jem\/article\/206\/6\/1219\/40628\/Inhibition-of-NK-cell-activity-by-IL-17-allows"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,25]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6,8]]}},"URL":"https:\/\/doi.org\/10.1084\/jem.20082835","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1161800.623405","asserted-by":"object"}]},"ISSN":["1540-9538","0022-1007"],"issn-type":[{"value":"1540-9538","type":"electronic"},{"value":"0022-1007","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5,25]]}}}